TAM
ADMS

Tocqueville Asset Management’s Adamas Pharmaceuticals ADMS Stock Holding History

Tocqueville Asset Management’s Portfolio ADMS Stock Details ADMS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-40,000
Closed -$656K – 866
2016
Q3 		$656K Hold
40,000
– – 0.01% 583
2016
Q2 		$606K Hold
40,000
– – 0.01% 596
2016
Q1 		$578K Hold
40,000
– – 0.01% 603
2015
Q4 		$1.13M Buy
40,000
+15,000
+60% +$253K 0.02% 518
2015
Q3 		$419K Hold
25,000
– – 0.01% 748
2015
Q2 		$656K Buy
+25,000
New +$486K 0.01% 650

Other funds holding ADMS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
BWCA
Brenner West Capital Advisors New York $804M AUM 16.19% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EMFAT
Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.06B AUM 106.87% 1-Year Est. Return
OTPPB
Ontario Teachers' Pension Plan Board Toronto, Ontario, Canada $3.46B AUM 7.79% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Tocqueville Asset Management's ADMS Position: Q4 2016 in Review

Tocqueville Asset Management sold out of Adamas Pharmaceuticals (ADMS) in Q4 2016, closing a stake of 40,000 shares — an estimated $656K sold.

Tocqueville Asset Management first reported a position in ADMS in Q2 2015 and held it in 6 quarters. The position peaked at $1.13M in Q4 2015. 78 funds tracked by Wall St. Rank hold ADMS as of Q4 2016.

  • Tocqueville Asset Management reported no remaining Adamas Pharmaceuticals position as of Q4 2016 after selling out during the quarter.
  • Tocqueville Asset Management sold 40,000 Adamas Pharmaceuticals shares in Q4 2016, an estimated $656K.
  • Tocqueville Asset Management first reported a position in Adamas Pharmaceuticals in Q2 2015 and held it in 6 quarters.
  • Tocqueville Asset Management's Adamas Pharmaceuticals position peaked at $1.13M in Q4 2015.
  • 78 funds tracked by Wall St. Rank held Adamas Pharmaceuticals as of Q4 2016.

Based on Tocqueville Asset Management's 13F filing for Q4 2016, filed 30 Jan 2017.